-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$8.87201.7% Upside
Autolus Therapeutics plc Frequently Asked Questions
-
What analysts cover Autolus Therapeutics plc?
Autolus Therapeutics plc has been rated by research analysts at Goldman Sachs, Wells Fargo, Truist Financial in the past 90 days.